Get a job referral to Repligen
Massachusetts, United States
501-1000 Employees
Automotive
•Healthcare
•Tech
Description
Repligen Corporation (NASDAQ: RGEN) is a leading life sciences company founded in 1981, specializing in the development and production of bioprocessing technologies. The company's innovative solutions, including chromatography and filtration systems, are essential in the manufacturing of biopharmaceuticals, vaccines, and gene therapies. Repligen's cutting-edge products play a crucial role in advancing research and improving the efficiency of bioproduction processes worldwide.
Jobs
Financials
Type
public
Annual Revenue
--
Market Cap
$8.1B+
Subscribe to Refer Me premium to get referred to your dream role at Repligen!